Cyclin K and cyclin D1b are oncogenic in myeloma cells
暂无分享,去创建一个
D. Dembélé | B. Sola | J. Wdzieczak‐Bakala | J. Renoir | B. Jost | Geoffroy Andrieux | Jack-Michel Renoir | Véronique Marsaud | G. Andrieux | V. Marsaud | Doulaye Dembele | Guergana Tchakarska | Jian‐Miao Liu | Bernard Jost | Brigitte Sola | Joanna Wdzieczak-Bakala | Guergana Tchakarska | Jian-Miao Liu
[1] J. Herman,et al. Identification of mutations that disrupt phosphorylation-dependent nuclear export of cyclin D1 , 2006, Oncogene.
[2] M. Roussel,et al. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. , 1998, Genes & development.
[3] J. Cigudosa,et al. Cyclin D1 gene (CCND1) mutations in endometrial cancer , 2003, Oncogene.
[4] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[5] J.M. Adams,et al. Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. , 1994, The EMBO journal.
[6] H. Rui,et al. Cyclin D1b protein expression in breast cancer is independent of cyclin D1a and associated with poor disease outcome , 2009, Oncogene.
[7] M. Lisanti,et al. Cyclin D1 induction of cellular migration requires p27(KIP1). , 2006, Cancer research.
[8] J. Diehl,et al. An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene. , 2003, Cancer research.
[9] M. Monden,et al. Antisense to Cyclin D1 Inhibits Vascular Endothelial Growth Factor–Stimulated Growth of Vascular Endothelial Cells: Implication of Tumor Vascularization , 2006, Clinical Cancer Research.
[10] G. Prendergast,et al. Alternate Cyclin D1 mRNA Splicing Modulates p27KIP1 Binding and Cell Migration* , 2008, Journal of Biological Chemistry.
[11] P. Nowell,et al. Mantle cell lymphoma cells express predominantly cyclin D1a isoform and are highly sensitive to selective inhibition of CDK4 kinase activity. , 2006, Blood.
[12] Chenguang Wang,et al. Minireview: Cyclin D1: normal and abnormal functions. , 2004, Endocrinology.
[13] B. Zhivotovsky,et al. Mitochondria in cancer cells: what is so special about them? , 2008, Trends in cell biology.
[14] B. Sola,et al. Alternative cyclin D1 forms a and b have different biological functions in the cell cycle of B lymphocytes. , 2007, Experimental cell research.
[15] M. Wasik,et al. Expression of constitutively nuclear cyclin D1 in murine lymphocytes induces B-cell lymphoma , 2006, Oncogene.
[16] A. Senderowicz,et al. Cyclin D1 Splice Variants , 2003, Journal of Biological Chemistry.
[17] C. Bassing,et al. Disruption of cyclin D1 nuclear export and proteolysis accelerates mammary carcinogenesis , 2007, Oncogene.
[18] Kenneth C. Anderson,et al. Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets , 2007, Nature Reviews Cancer.
[19] J. Gray,et al. The Role of p53 in Suppression of KSHV Cyclin-induced Lymphomagenesis , 2004, Cancer Research.
[20] L. Staudt,et al. Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma. , 2004, Cancer cell.
[21] Gonzalez,et al. Insights into the multistep transformation of MGUS to myeloma using microarray expression analysis. , 2003, Blood.
[22] O. Delattre,et al. Alteration of cyclin D1 transcript elongation by a mutated transcription factor up-regulates the oncogenic D1b splice isoform in cancer , 2008, Proceedings of the National Academy of Sciences.
[23] B. Sola,et al. Relevance of cyclin D1b expression and CCND1 polymorphism in the pathogenesis of multiple myeloma and mantle cell lymphoma , 2006, BMC Cancer.
[24] J L Cleveland,et al. Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation. , 2000, Genes & development.
[25] H. Rui,et al. Cyclin D1b is aberrantly regulated in response to therapeutic challenge and promotes resistance to estrogen antagonists. , 2008, Cancer research.
[26] H. Kiyokawa,et al. Eukaryotic initiation factor 6 is rate-limiting in translation, growth and transformation , 2008, Nature.
[27] Tom C. Freeman,et al. An open-access long oligonucleotide microarray resource for analysis of the human and mouse transcriptomes , 2006, Nucleic acids research.
[28] Y. Yuzawa,et al. A Small Interfering RNA Targeting Vascular Endothelial Growth Factor as Cancer Therapeutics , 2004, Cancer Research.
[29] T. Golub,et al. A Mechanism of Cyclin D1 Action Encoded in the Patterns of Gene Expression in Human Cancer , 2003, Cell.
[30] Anping Li,et al. Cyclin D1 Determines Mitochondrial Function InVivo , 2006, Molecular and Cellular Biology.
[31] Chenguang Wang,et al. Cyclin D1 repression of nuclear respiratory factor 1 integrates nuclear DNA synthesis and mitochondrial function. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[32] Leonhard Müllauer,et al. Genome-wide transcriptional response to 5-aza-2'-deoxycytidine and trichostatin a in multiple myeloma cells. , 2008, Cancer research.
[33] A. Bikfalvi,et al. Domain swapping in a COOH-terminal fragment of platelet factor 4 generates potent angiogenesis inhibitors. , 2002, Cancer research.
[34] P. L. Bergsagel,et al. Molecular pathogenesis and a consequent classification of multiple myeloma. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[35] J. D. Vos,et al. Comparison of gene expression profiling between malignant and normal plasma cells with oligonucleotide arrays , 2002, Oncogene.
[36] N Thatcher,et al. Alternate splicing produces a novel cyclin D1 transcript. , 1995, Oncogene.
[37] P. Ojala,et al. Cell signaling pathways engaged by KSHV. , 2006, Biochimica et biophysica acta.
[38] D. Carrasco,et al. Identification of genes modulated in multiple myeloma using genetically identical twin samples. , 2004, Blood.
[39] H. Lovec,et al. Cyclin D1/bcl‐1 cooperates with myc genes in the generation of B‐cell lymphoma in transgenic mice. , 1994, The EMBO journal.
[40] T. Rème,et al. Induction of angiogenesis by normal and malignant plasma cells. , 2009, Blood.
[41] O. Coqueret,et al. Kaposi sarcoma-associated viral cyclin K overrides cell growth inhibition mediated by oncostatin M through STAT3 inhibition. , 2003, Blood.
[42] E. Campo,et al. Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics , 2007, Nature Reviews Cancer.
[43] M. Yaniv,et al. The human SWI/SNF subunit Brm is a regulator of alternative splicing , 2006, Nature Structural &Molecular Biology.
[44] J. Woodgett,et al. A molecular compendium of genes expressed in multiple myeloma. , 2002, Blood.
[45] J. Heighway,et al. Induced expression of human CCND1 alternative transcripts in mouse Cyl‐1 knockout fibroblasts highlights functional differences , 2005, International journal of cancer.
[46] J. Ladias,et al. Crystal structure of human cyclin K, a positive regulator of cyclin-dependent kinase 9. , 2007, Journal of molecular biology.